TR199900288T1 - Farmas�tik aerosol bile�imi. - Google Patents

Farmas�tik aerosol bile�imi.

Info

Publication number
TR199900288T1
TR199900288T1 TR1999/00288T TR9900288T TR199900288T1 TR 199900288 T1 TR199900288 T1 TR 199900288T1 TR 1999/00288 T TR1999/00288 T TR 1999/00288T TR 9900288 T TR9900288 T TR 9900288T TR 199900288 T1 TR199900288 T1 TR 199900288T1
Authority
TR
Turkey
Prior art keywords
aerosol
farmas
tik
imi
bile
Prior art date
Application number
TR1999/00288T
Other languages
English (en)
Turkish (tr)
Inventor
Lewis David
Ganderton Davis
Meakin Brian
Ventura Paolo
Brambilla Gaetano
Garzia Raffaella
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199900288(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of TR199900288T1 publication Critical patent/TR199900288T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR1999/00288T 1997-06-13 1998-06-10 Farmas�tik aerosol bile�imi. TR199900288T1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
TR199900288T1 true TR199900288T1 (xx) 1999-09-21

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00288T TR199900288T1 (xx) 1997-06-13 1998-06-10 Farmas�tik aerosol bile�imi.

Country Status (44)

Country Link
EP (2) EP0920302B2 (enExample)
JP (1) JP4380802B2 (enExample)
KR (1) KR100546239B1 (enExample)
CN (1) CN1138532C (enExample)
AR (1) AR012977A1 (enExample)
AT (1) ATE222751T1 (enExample)
AU (1) AU729966B2 (enExample)
BG (1) BG63906B1 (enExample)
BR (1) BR9805993B1 (enExample)
CA (1) CA2263445C (enExample)
CO (1) CO4940408A1 (enExample)
CZ (1) CZ295521B6 (enExample)
DE (1) DE69807420T3 (enExample)
DK (1) DK0920302T4 (enExample)
DZ (1) DZ2516A1 (enExample)
EA (1) EA001259B1 (enExample)
EE (1) EE03664B1 (enExample)
ES (1) ES2182351T5 (enExample)
GB (1) GB2326334A (enExample)
GE (1) GEP20012462B (enExample)
HR (1) HRP980317B1 (enExample)
HU (1) HU228487B1 (enExample)
ID (1) ID21491A (enExample)
IL (1) IL128484A (enExample)
IN (1) IN189317B (enExample)
IS (1) IS2435B (enExample)
IT (1) IT1293803B1 (enExample)
MA (1) MA26507A1 (enExample)
ME (2) ME00333B (enExample)
MY (1) MY119074A (enExample)
NO (1) NO327775B1 (enExample)
NZ (1) NZ334149A (enExample)
PL (1) PL193721B1 (enExample)
PT (1) PT920302E (enExample)
RS (1) RS51274B (enExample)
SA (1) SA98190821B1 (enExample)
SI (1) SI0920302T2 (enExample)
SK (1) SK284430B8 (enExample)
TN (1) TNSN98087A1 (enExample)
TR (1) TR199900288T1 (enExample)
TW (1) TW555570B (enExample)
UA (1) UA70289C2 (enExample)
WO (1) WO1998056349A1 (enExample)
ZA (1) ZA985136B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317904B1 (it) 1999-09-11 2003-07-15 Glaxo Group Ltd Formulazione farmaceutica di propionato di fluticasone.
ES2234694T3 (es) * 1999-11-23 2005-07-01 Glaxo Group Limited Formulaciones farmaceuticas de salmeterol.
US20030032632A1 (en) * 1999-12-24 2003-02-13 Crispps Leslie Alan Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
EE05167B1 (et) 2000-05-22 2009-06-15 Chiesi Farmaceutici S.P.A. Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
ME00077B (me) 2002-03-01 2010-06-10 Chiesi Farm Spa Formoterol najfiniji preparat
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ES2275778T3 (es) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. Solubilizacion de farmacos en propulsores de hfa mediante emulsiones.
EP1599184A4 (en) * 2003-02-04 2009-06-24 Chrysalis Tech Inc FULLY HALOGENATED FLUOROCARBON HYDROGEN AND HYDROFLUOROCHLOROUS HYDROGEN FUELS AND METHOD FOR THE PRODUCTION AND USE THEREOF
ES2304616T3 (es) * 2003-03-20 2008-10-16 Boehringer Ingelheim Pharmaceuticals Inc. Formulacion para un inhalador con dosis medida utilizando hidro-fluoro-alcanos como propulsores.
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
BRPI0512878A (pt) 2004-07-02 2008-04-15 Boehringer Ingelheim Int formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
BRPI0819259A2 (pt) * 2007-11-07 2019-10-01 Astrazeneca Ab formulações de pó seco compreendendo derivados do ácido ascórbico.
BR112013005284A2 (pt) * 2010-09-06 2019-09-24 Chiesi Farm Spa inalador dosimetrado e uso de um inalador dosimetrado
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
EP3436115B1 (en) 2016-03-31 2021-07-28 Chiesi Farmaceutici S.p.A. Aerosol inhalation device
MY210122A (en) * 2016-09-19 2025-08-28 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE71520T1 (de) † 1986-03-10 1992-02-15 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
JP2573275B2 (ja) † 1986-03-10 1997-01-22 ブルグハルト，クルト 薬学的製剤及びその製造法
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
ATE114112T1 (de) † 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
PT656206E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
US6503482B1 (en) † 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
DK0717987T3 (da) * 1991-12-18 2001-11-12 Minnesota Mining & Mfg Suspension-aerosol-formuleringer
ES2129117T3 (es) * 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
EP0759744B1 (en) † 1994-05-13 2001-10-17 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
WO1998024420A1 (en) † 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Pharmaceutical compositions and devices for their administration
US6461591B1 (en) † 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations

Also Published As

Publication number Publication date
ATE222751T1 (de) 2002-09-15
DE69807420T2 (de) 2003-05-08
TW555570B (en) 2003-10-01
SA98190821B1 (ar) 2006-11-19
CN1229355A (zh) 1999-09-22
SK284430B8 (sk) 2005-05-05
BG103221A (bg) 1999-09-30
NO327775B1 (no) 2009-09-21
EP0920302B1 (en) 2002-08-28
BR9805993A (pt) 1999-08-31
MEP44008A (hr) 2011-02-10
ITMI971798A1 (it) 1999-01-28
HUP0001339A3 (en) 2000-10-30
JP2000516965A (ja) 2000-12-19
IS4974A (is) 1999-02-11
ES2182351T5 (es) 2007-03-16
JP4380802B2 (ja) 2009-12-09
CA2263445A1 (en) 1998-12-17
EP1219293A2 (en) 2002-07-03
PL331531A1 (en) 1999-07-19
DK0920302T3 (da) 2002-12-23
EE03664B1 (et) 2002-04-15
CZ295521B6 (cs) 2005-08-17
AR012977A1 (es) 2000-11-22
PL193721B1 (pl) 2007-03-30
EP1219293A3 (en) 2003-05-28
SI0920302T2 (sl) 2006-10-31
KR20000068171A (ko) 2000-11-25
GB9712434D0 (en) 1997-08-13
GEP20012462B (en) 2001-06-25
SK284430B6 (sk) 2005-04-01
CZ46299A3 (cs) 1999-07-14
EA199900201A1 (ru) 1999-06-24
CA2263445C (en) 2008-09-09
UA70289C2 (uk) 2004-10-15
MA26507A1 (fr) 2004-12-20
EA001259B1 (ru) 2000-12-25
WO1998056349A1 (en) 1998-12-17
YU6999A (sh) 2000-03-21
ZA985136B (en) 1999-01-07
AU8626298A (en) 1998-12-30
NO990594L (no) 1999-04-13
SI0920302T1 (sl) 2002-12-31
ES2182351T3 (es) 2003-03-01
CO4940408A1 (es) 2000-07-24
HU228487B1 (en) 2013-03-28
RS51274B (sr) 2010-12-31
TNSN98087A1 (fr) 2005-03-15
SK17699A3 (en) 1999-07-12
EE9900055A (et) 1999-08-16
HUP0001339A2 (hu) 2000-09-28
CN1138532C (zh) 2004-02-18
DE69807420T3 (de) 2006-11-16
NO990594D0 (no) 1999-02-09
IS2435B (is) 2008-10-15
HRP980317B1 (en) 2002-06-30
NZ334149A (en) 2000-07-28
PT920302E (pt) 2002-11-29
DZ2516A1 (fr) 2004-11-08
IL128484A0 (en) 2000-01-31
ID21491A (id) 1999-06-17
DE69807420D1 (de) 2002-10-02
EP0920302A1 (en) 1999-06-09
HRP980317A2 (en) 1999-04-30
IN189317B (enExample) 2003-02-08
DK0920302T4 (da) 2006-10-09
KR100546239B1 (ko) 2006-01-26
HK1022271A1 (en) 2000-08-04
IL128484A (en) 2004-09-27
AU729966B2 (en) 2001-02-15
ME00333B (me) 2011-02-10
IT1293803B1 (it) 1999-03-10
MY119074A (en) 2005-03-31
EP0920302B2 (en) 2006-06-21
BG63906B1 (bg) 2003-06-30
BR9805993B1 (pt) 2009-05-05
GB2326334A (en) 1998-12-23

Similar Documents

Publication Publication Date Title
EA199900201A1 (ru) Фармацевтическая аэрозольная композиция
ES2106362T3 (es) Polvo de inhalacion que contiene un agente antiestatico.
NL7903542A (nl) Electrochemische cel met gasdepolarisatie; werkwijze voor het beperken van het toetreden van zuurstof bij de kathode van een electrochemische cel met gasdepola-- risatie.
TW347341B (en) Method for delivering a liquid fire suppression agent to a fire with a separate pressurized gas
ATE254095T1 (de) Selektive analoge der thyroidhormone
TR199900379T2 (xx) Klorofluorokarbon i�ermeyen mometazon furoat aerosol form�lasyonlar�.
JPS51138228A (en) Exhaust circulation device
IE43581L (en) 3-oximes of d-norgestrel ester
JPS53145103A (en) Solid handling pump for use in changing fine particle or powdered fuel into gas and method of operating the pump
NL7801355A (nl) Inrichting voor het dempen van pulsaties in een installatie voor het verdampen van laag- kokende vloeibaar gemaakte gassen.
DK1100528T3 (da) Anvendelse af hidtil ukendte midler, der inducerer celledød i samvirke med interferoner
JPS5556190A (en) Odorant for fuel gas
JPS5368498A (en) Laser machining gun
ES2196364T3 (es) Sordarina y sus derivados para uso como agentes antifungicos en cultivos.
JPS5226034A (en) Oil burner
JPS53101535A (en) Deodorant comosition
NO985110L (no) Eksplosivformuleringer
JPS52102433A (en) Hypotensive agents containing 1,4-dihydroxy-1,4-di-(3,5-dimethoxy-4-hy droxyphenyl)butane-2,3-dicarboxylic acid dilactone as main component
JPS51130929A (en) Combustion method for gaseous fuel
NO830751L (no) Fremgangsmaate til etterforbrenning av brennbare bestanddeler i avgasser fra dreieroersovner
JPS5344972A (en) Electric dust collector for test
JPS5310141A (en) Burning equipment
JPS543699A (en) Protector of ion source
ES2121782T3 (es) Composicion antineoplasica.
JPS52124513A (en) Compressed mixture reflux device for rotary piston engine